Research
Research areas are derived from OpenAlex topics of their publications.
From the 150 most recent of 274 publications.
Real-world experience and outcomes of decitabine/cedazuridine or azacitidine for the treatment of myelodysplastic syndrome/chronic myelomonocytic leukemia
Salter B, Ge S, Garcia-Horton A, Berg T, Leber B, Walker I, Dalmia S, Radford M, Lepic K, Khalaf D
A Randomized Pilot Trial comparing Anti-Thymocyte Globulin (ATG) with ATG plus Post Transplant Cyclophosphamide (PTCy) for Prophylaxis against Acute and Chronic Graft Versus Host Disease (GVHD) in Matched Donor Hematopoietic Cell Transplants (HCT)
Walker I, Deotare U, Elemary M, Elsawy M, Gallagher G, Kliman D, Panzarella T, Hamad N, Schultz K, Storek J
Impact of Modern Strategies for Graft‐Versus‐Host Disease Prophylaxis on Relapse Risk in Matched‐Sibling or Unrelated Donor Hematopoietic Cell Transplantation: A Systematic Review and Meta‐Analysis of Randomized Trials
Arcuri LJ, Natal VHG, Américo AD, Perini G, Kerbauy MN, Kerbauy LN, Lima ACM, De León AG, Ribeiro AAF, de Souza Santos FP
Correction: Impact of expanding allogeneic stem cell transplantation on survival in acute myeloid leukemia: a population-based study
Salter B, Garcia-Horton A, Walker I, Leber B, Lepic K, Mian H, Gayowsky A, Pond GR, Seow H, Berg T
Chimerism practices across Canadian transplant centres: review of current standards and variations
Gravina M, Lepic K, Leber B, Walker I, Berg T, Lam W, Garcia-Horton A, Dalmia S, Grafodatskaya D, Butcher DT
A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants – a study from the Cell Therapy Transplant Canada/ Australasian Leukemia Lymphoma Group Consortium
Walker I, Deotare U, Elemary M, Elsawy M, Gallagher G, Kliman D, Panzarella T, Hamad N, Schultz KR, Storek J
Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDS
Radford M, Garcia-Horton A, Badami R, Jin E, Usmani N, Grafodatskaya D, McCready E, Khalaf D, Walker I, Leber B
Impact of expanding allogeneic stem cell transplantation on survival in acute myeloid leukemia: a population-based study
Salter B, Garcia-Horton A, Walker I, Leber B, Lepic K, Mian H, Gayowsky A, Pond GR, Seow H, Berg T
Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma
Ge S, Lepic K, Bhindi R, Berg T, Khalaf D, Leber B, Radford M, Walker I, Davies G, Garcia-Horton A
Early Cardiovascular Events in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
Aghel N, Wang V, Leong D, Lui M, Fu L, Kang J, Khalaf D, Walker I, Hillis C, Leber B
Frequent collaborators
78Researchers with similar interests
Kylie Lepic
Oncology
Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research
Alfonso Iorio
Health Research Methods, Evidence, and Impact
Hemophilia Treatment and Research, Platelet Disorders and Treatments
Nasrin Samji
Pediatrics
Hemophilia Treatment and Research, Platelet Disorders and Treatments
Alejandro Garcia Horton
Oncology
Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research
Menaka Pai
Medicine
Platelet Disorders and Treatments, Hemophilia Treatment and Research
Tobias Berg
Oncology
Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.